The realization that autoantibodies can contribute to dysfunction of the brain has brought
about a paradigm shift in neurological diseases over the past decade, offering up important …

Seizures are a well‐recognized and often prominent manifestation of autoimmune
encephalitic syndromes. Progress in detection of pathogenic neural autoantibodies has led …

Faciobrachial dystonic seizures and limbic encephalitis closely associate with antibodies to
leucine-rich glioma-inactivated 1 (LGI1). Here, we describe 103 consecutive patients with …

Objective This nationwide cohort study evaluates seizure responses to immunotherapy and
antiepileptic drugs (AEDs) in patients with anti-leucine-rich glioma-inactivated 1 (LGI1), anti …

Autoimmune encephalitis is one of the most rapidly growing research topics in neurology.
Along with discoveries of novel antibodies associated with the disease, clinical experience …

The discovery, in 2010, of autoantibodies against the extracellular proteins LGI1 and Caspr2
facilitated a change of view regarding the clinical importance of voltage-gated potassium …

Measurement of hippocampal volume has proven useful to diagnose and track progression
in several brain disorders, most notably in Alzheimer's disease (AD). For example, an …

Objective To compare acute treatment responses and long-term outcome in leucine-rich
glioma-inactivated 1 (LGI1) antibody encephalitis. Methods Retrospective case series of 118 …

Objective To perform a systematic review of the current scientific literature in order to identify
variables associated with patient prognosis in autoimmune encephalitis. Methods We …

Recent biochemical observations have helped redefine antigenic components within the
voltage-gated potassium channel (VGKC) complex. The related autoantibodies may be now …